Cytomegalovirus (CMV) is a ubiquitous virus, causing the most common congenital infection in humans, yet a vaccine against this virus is not available. Experimental studies of immunity against CMV in animal models of infection, such as the infection of mice with mouse CMV (MCMV), have relied mainly on parenteral infection protocols, although the virus naturally transmits by mucosal routes via body fluids. To characterize the biology of infections by mucosal routes, we compared the kinetics of virus replication, latent viral load and CD8 T-cell responses in lymphoid organs upon experimental intranasal (targeting the respiratory tract) and intragastric (targeting the digestive tract) infection with systemic intraperitoneal infection of two unrelated mouse strains. We observed that intranasal infection induced robust and long-term virus replication in the lungs and salivary glands but limited replication in the spleen. CD8 T-cell responses were somewhat weaker than upon intraperitoneal infection but showed similar kinetic profiles and phenotypes of antigen-specific cells. In contrast, intragastric infection resulted in abortive or poor virus replication in all tested organs and poor T-cell responses to the virus, especially at late times after infection. Consistent with the T-cell kinetics, the MCMV latent load was high in the lungs but low in the spleen of intranasally infected mice and lowest in all tested organs upon intragastric infection. In conclusion, we showed that intranasal but not intragastric infection of mice with MCMV represents a robust model to study the short-and long-term biology of CMV infection by a mucosal route.
INTRODUCTION
Cytomegalovirus (CMV) infection is the most common congenital viral infection in developed countries (Kenneson and Cannon, 2007; Griffiths et al., 2015) . Congenital human CMV (HCMV) infections occur upon infection or reinfection of adult women during pregnancy (Boppana et al., 2001; Fowler et al., 2003) . Infection can also occur via blood transfusion and organ transplantation, which is especially problematic in immunosuppressed seronegative recipients, where such an infection may cause severe disease. The exact natural route of transmission and entry into the body of most hosts infected with CMV post-partum remains, however, uncertain. While it is reasonable to assume that infection occurs via mucosal surfaces exposed to infectious secretions, the exact route(s) is difficult to identify by epidemiological studies. HCMV can be shed for months, if not years, upon infection by numerous body fluids (Cannon et al., 2011) , arguing that CMV may naturally transmit itself by more than one means of infection. Numerous studies have shown that HCMV shedding by breast milk (Diosi et al., 1967) may be a way of transmission (Stagno et al., 1980; Dworsky et al., 1983) , especially in pre-term infants (Vochem et al., 1998) .
Sexual activity may present a risk factor for HCMV infection in adult women (Fowler and Pass, 1991) , and CMV infection is common in day-care workers attending very young children (Adler, 1989) . However, multiple body fluids are likely to be exchanged simultaneously during the close contacts that are required for infection, and the lack of pathognomonic symptoms complicates the epidemiological study of HCMV transmission in adults.
Experimental studies of transmission in animal models, on the other hand, are limited to HCMV-orthologuous viruses, such as rhesus CMV (RhCMV) and murine CMV (MCMV), due to the strict species specificity of CMVs. Nevertheless, the mouse model of CMV infection has provided deep insight in CMV pathogenesis and immunity and reflects numerous aspects of HCMV biology (Redwood et al., 2013) . Surprisingly, little is known about the natural route of infection by MCMV. While intranasal MCMV infection of adult mice has been used occasionally in previous studies (Jordan, 1978; Shanley et al., 1997; Morello et al., 2005) , the only effort to systematically compare it with other routes of infection relied on low infection doses and was limited in its interpretation because of wide variations of outcomes between cages (Doom and Hill, 2008) . A study on a model of neonate mouse infection reported that a transgenic MCMV, expressing mCherry as a reporter gene, could be found in the lungs of neonates infected by the laryngopharyngeal route and in adult mice infected intranasally (i.n.) (Stahl et al., 2013) . This study used a molecular clone of MCMV lacking the viral protein Mck-2 (Saederup et al., 2001) , and a subsequent study by the same group showed that Mck-2 is a determinant of viral pathogenicity in lungs of neonate mice infected by the laryngopharyngeal route (Stahl et al., 2015) . Therefore, the replication and immune response to mucosal infections by a wt MCMV remain unknown.
In contrast, the well-studied model of adult mouse infection has relied on systemic infection of mice by the intraperitoneal (i.p.) (Munks et al., 2006) or intravenous (i.v.) (Karrer et al., 2003) route, or by injection of the virus into the footpad, assuming that this may mimic a putative transmission by mouse bites . Parenteral infection results in MCMV dissemination to multiple organs during a primary viraemia phase, with a secondary viraemia delivering the virus to the salivary glands . This also results in a remarkably robust CD8 T-cell response (Č ičin-Šain et al., 2012) , where virus-specific CD8 T-cells accumulate at the time of virus latency , a phenomenon aptly named memory inflation (Karrer et al., 2003; O'Hara et al., 2012) . Inflationary responses were shown to consist predominantly of CD62L 2 effector memory (EM) cells (Holtappels et al., 2000; Karrer et al., 2003) , implying a recent antigenic encounter, and similar types of responses were observed in natural and experimental rhesus monkey infection with RhCMV (Pitcher et al., 2002; Hansen et al., 2009; Č ičin-Šain et al., 2011) or in people carrying latent HCMV (Appay et al., 2002) . However, it has remained unclear whether mucosal infection would elicit such responses.
To define the mucosal route reflecting the natural infection of an adult host, and whether this would result in CD8 T-cell responses matching those upon systemic infection, we compared the kinetics of virus replication, latent viral load and CD8T-cell responses in mice infected by the i.n., gastric lavage (gavage) and i.p. routes. We observed that i.n. infection resulted in robust virus replication during primary infection and secondary dissemination to the salivary glands, as well as elevated latent loads in the lungs, whereas gavage infection was either abortive or resulted in poor virus replication and very low latent loads in the tested organs. Inflationary responses were less pronounced upon mucosal infection than upon systemic infection but were clearly noticeable in all tested compartments upon i.n. infection. Therefore, the data presented here suggest that i.n. MCMV infection may be a suitable model of infection of adult mice, and may potentially be a model of natural mucosal CMV infection.
RESULTS

I.n. MCMV infection results in robust virus replication in the lungs, whereas infection by gavage is inefficient
Virus replication upon mucosal infection was compared with systemic infection via the i.p. route by determining infectious virus titres in spleens and lungs of BALB/c mice at 5 and 14 days post-infection (p.i.), as well as in salivary glands at 14 days p.i. In mice infected with MCMV by gavage, infectious virus in the spleen and lungs was almost undetectable. In half of these mice, salivary gland MCMV titres were substantially lower than in i.p.-infected controls (Fig. 1a) . In contrast, i.n. infection induced higher viral titres in the lungs than i.p. injection. In contrast, titres in spleens were reduced after i.n. infection. Spread to the salivary glands had nearly the same efficiency via both infection routes (Fig. 1a) . As high virus titres in the salivary glands are deemed important for transmission to the next host, our results suggest that transmission of MCMV in mice occurs via the respiratory rather than the gastrointestinal tract. Hence, we analysed MCMV replication after infection via this route in more detail.
Virus titres were determined for 1 week in spleen and lung samples harvested daily from mice infected i.n. or i.p., and at 10 days p.i. Virus was detected in the lungs of i.n.-infected mice as soon as 1 day p.i., and titres were increased several orders of magnitude above those in mice infected by the i.p. route at all tested time points. It is important to note that i.n.-infected mice showed no obvious symptoms of disease at any time point, despite the persistence of very high virus titres in their lungs. In a separate experiment, spleen, lung and salivary glands were analysed for infectious virus titres at 7, 14 and 21 days p.i. Elevated titres in the lungs could be detected even at 21 days p.i. (Fig. 1c) , and some infectious virus could be detected in some mice as late as 42 days p.i.
(not shown). In contrast, low titres of infectious virus were detectable in the spleen only from 5 to 7 days p.i. after i.n. infection, whereas i.p. infection induced substantially higher infectious titres, which peaked at 4 days p.i. and could still be detected by 21 days p.i. (Fig.  1b, c) . Virus titres in salivary glands of i.n. or i.p. infected mice were comparable at all tested time points (Fig. 1c) .
IE1-specific CD8 T-cells inflate in the blood after i.n. infection
After systemic MCMV infection, CD8 T-cells recognizing defined immunodominant peptides have been shown to accumulate after clearance of lytic virus replication, a phenomenon known as memory inflation Karrer et al., 2003; Sierro et al., 2005; Munks et al., 2006; O'Hara et al., 2012) . In order to test whether memory inflation is induced upon mucosal MCMV infection, we compared CD8 T-cell kinetics after i.n. infection and infection by gavage with systemic infection by the i.p. route. We monitored CD8 T-cells for their response to MCMV infection in the peripheral blood for up to 6 months p.i. Mice that showed no CD8 T-cell response above background at any tested time point were excluded from the CD8 T-cell analysis, to censor false-negative events due to inefficient primary infection. It should be noted that these events occurred only in gavage infection, consistent with data showing the absence of infectious virus titres in organs (see Fig. 1a ). The representative gating strategy for the flow cytometry analysis is depicted in Fig. S1 (available in the online Supplementary Material).
First, the percentage and absolute numbers of primed CD8 T-cells (defined by CD11 high /CD44 high ) were monitored. Primed cells displayed a strong initial increase in mice infected via the i.p. route by 1 week after infection, which contracted slightly by week 4 and remained rather stable in relative and absolute terms later on. The initial increase was delayed for 1 week after mucosal infection and the obtained values were clearly lower than after i.p. infection. After a contraction at around week 4, the frequency of primed CD8 T-cells remained rather stable in i.n.-infected mice but decreased to background level in the gavage-infected group (Fig. 2a, left panel) . The absolute numbers of primed cells upon mucosal infection was barely elevated over the levels observed in uninfected mice (Fig. 2a , right panel). While the difference was small, mice infected via the i.n. route showed a higher frequency and number of primed CD8 T-cells than mice infected by gavage at all time points (Fig. 2a) . Next, we analysed the CD8 T-cell response to an immunodominant MCMVderived epitope; the IE1 168-176 epitope, which induces CD8 T-cells with an inflationary phenotype in mice with the H-2 d haplotype (e.g. BALB/c mice) Karrer et al., 2003; Sierro et al., 2005) . We used an MHC class I tetramer (IE1-tetramer) to stain IE1-specific CD8 T-cells and detect them via flow cytometry. In mice infected by the i.p. route, we observed the previously reported inflationary kinetic profile of IE1-specific CD8 T-cells, with highly elevated relative and absolute counts throughout the time course of the experiment (Fig. 2b) . Consistent with the kinetics of primed cells, the initial peak of IE1-specific responses occurred later (in week 2 p.i.) upon both mucosal infection routes. Whereas the frequency and counts of IE1-specific CD8 T-cells declined in mice infected by gavage by week 4 p.i. and remained low thereafter, in i.n.-infected mice the percentage and absolute number increased from week 4 to week 13 and stayed constant thereafter (Fig. 2b) . IE1-specific responses after i.n. infection were weaker than after i.p. infection, and this difference was more obvious for absolute (Fig. 2b , right panel) than for relative (Fig. 2b, left panel) numbers. These data suggested a hierarchy of CD8 T-cell responses upon the three infection routes tested: responses were clearly strongest after i.p. infection, followed by i.n. infection and only then by gavage inoculation.
IE1-specific CD8 T-cells inflate in lymphoid organs after i.n. infection
The robust T-cell response in mice infected via the i.n. route prompted us to examine it in more detail. Therefore, we investigated the virus-specific responses in several lymphoid compartments in addition to the blood by determining the kinetics of primed and MCMV-specific CD8 T-cells in the spleen, the mediastinal lymph nodes (MLNs) and the inguinal lymph nodes (ILNs) of BALB/c mice. The MLNs are the draining lymph nodes of the lungs and have been shown to also drain substances administered via the i.p. route (Marco et al., 1992; Hsu et al., 2009; Kirby et al., 2009; Ple et al., 2010) , while the ILNs are used as non-draining lymph nodes.
The kinetics of primed and IE1-specific CD8 T-cells (Fig. 3a) in the blood were in essence comparable to the results of the previous experiment (Fig. 2) , although the absolute numbers in i.p.-infected mice were lower in this experiment, resulting in a smaller difference compared with mice infected via the i.n. route. In both infection routes, the kinetics of CD8 T-cells in the spleen (Fig. 3b) closely mimicked those in the blood (Fig. 3a) . Both the percentages and the numbers of primed and IE1-specific CD8 T-cells were much lower in the lymph nodes in general (Fig. 3c, d ). The percentages of both primed and MCMV-specific CD8 T-cells increased in the non-draining ILNs only at late time points but remained lower, as in the blood or spleen (Fig. 3c, first and third panels) . Notably, the increase in the frequency of primed CD8 T-cells was also detected in uninfected controls, suggesting that it may be a function of exposure to environmental antigens in ageing mice, rather than caused by MCMV infection. The numbers of primed CD8 T-cells remained very low throughout the experiment, with the exception of a transient increase in i.p.-infected mice at 1 week p.i. (Fig. 3c , second panel), which was also reflected as an early peak in the count of IE1-specific cells (Fig. 3c, fourth panel) . Furthermore, total counts of IE1-specific cells increased in both infection groups at later time points but again much less than in blood or spleen (Fig. 3c, fourth panel) . In the MLNs of i.n.-infected mice, the absolute count of primed and IE1-specific CD8 T-cells exceeded those after i.p. infection early upon infection (Fig. 3d , second and fourth panel), but this was reversed for primed cells by 13 weeks p.i. (Fig. 3d, second panel) . In contrast, the percentage and number of IE1-specific CD8 T-cells was comparable in the MLNs of i.p.-and i.n.-infected mice at later time points (Fig. 3d, third and fourth panel) .
In summary, these data suggest that i.n. infection initiates a robust MCMV-specific T-cell response in the draining lymph node and induces memory inflation, not only in the blood but also in the spleen and lymph nodes.
MCMV-specific CD8 T-cells inflate after i.n. infection of 129/Sv mice
To exclude the possibility that these results are restricted to the BALB/c mouse strain, we analysed the kinetics of the CD8 T-cell response in the blood upon mucosal MCMV infection in mice of the 129/Sv strain. Like BALB/c mice, these mice do not express the resistant Cmv1 allele (Scalzo et al., 1995) , and thus display similar levels of CMV control by NK cells. We analysed the kinetics of primed CD8 T-cells and CD8 T-cells specific for an inflationary K b -restricted epitope corresponding to aa 316-323 of the M38 protein of MCMV (Munks et al., 2006) .
The largest discrepancy between BALB/c and 129/Sv mice was observed upon gavage infection. Namely, 23 out of 35 129/Sv mice showed no MCMV-specific response to infection at any time point, whereas this was the case in only two out of 20 BALB/c mice. Among the mice showing responses, the kinetics of primed and M38-specific CD8 T-cells displayed the same hierarchy as observed for primed and IE1-specific cells in the BALB/c model (Fig. 2) . Systemic i.p. infection induced the strongest inflationary response, followed by i.n. infection, which still induced inflating M38-specific CD8 T-cells but at a lower level than i.p. infection. Infection by gavage resulted in the weakest response and no increase of antigen-specific CD8 T-cells after 4 weeks of infection (Fig. 4a, b) . At least five mice per group were sacrificed and used for detailed analysis at 2 weeks p.i. The rest (at least seven mice per group) were analysed at the indicated time points p.i. Blood from five mice was analysed prior to infection, to define the basis of the CD8 T-cell fractions. For the analysis of CD8 T-cell subsets, blood leukocytes were stained with an IE1-tetramer and with antibodies against CD3, CD4, CD8a, CD11a and CD44, and analysed by flow cytometry. 
Most primed CD8 T-cells display an EM phenotype upon intranasal infection
Most inflationary CD8 T-cells show an EM phenotype after systemic i.p. infection, characterized by low expression of CD62L and high expression of KLRG1.
In contrast, non-inflationary cells usually assume a central memory (CM) phenotype (Sierro et al., 2005; Snyder et al., 2008) , defined here as CD62L high KLRG1 low . We analysed the phenotype of primed CD8 T-cells upon MCMV infection in 129/Sv mice and observed that most primed CD8 Tcells of i.p.-infected mice assumed an EM phenotype n. route. PBS (20 ml) was administered via the intranasal route to mockinfected controls. The first cohort consisted of 25 mice per group, sacrificed at weeks 1, 2, 4, 13 and 27, and the second cohort of 10 mice per group analysed at week 1 or 27 only. Samples from five mice were collected prior to infection to set the baseline of CD8 T-cell subsets (time point 0). At the indicated time points p.i., the frequency and absolute counts of primed (CD11a
-cells were determined in the blood (a), spleen (b), ILNs (c) inguinal and MLNs (d). Leukocytes
were stained with an IE1-tetramer and antibodies against CD3, CD4, CD8a, CD11a and CD44 and analysed by flow cytometry. Displayed are the group means¡SEM (n$3) at the indicated time points; combined data from both cohorts are shown at 1 and 27 weeks p.i. Absolute counts are shown per 100 ml blood, per whole spleen or per lymph node.
(KLRG1 + CD62L
2 ) throughout the infection. This percentage was slightly lower in mice infected via the i.n. route, but the lowest percentage was observed upon gavage or in uninfected mice (Fig. 4c) . For cells displaying a CM phenotype, the hierarchy was inverted (Fig. 4d) . The kinetics of the CM and EM phenotypes were similar in BALB/c mice, with most EM cells upon systemic infection, the least in uninfected mice and intermediate phenotypes in the two mucosal infections (data not shown).
The phenotype of M38-specific CD8 T-cells was also analysed in different compartments (blood, spleen, ILNs and MLNs) at an early (week 2) and a late (week 26) time point after infection. Early after infection, the phenotype was comparable among all infection routes, with more KLRG1 + CD62L 2 M38-specific cells in the blood and spleen (Fig. 4e, upper panel) and with more KLRG1
2
CD62L
+ M38-specific cells in the lymph nodes (Fig. 4e,  lower panel) . Later after infection, this distribution remained the same, but mice infected by gavage clearly had fewer EM cells and more CM cells in M38-specific CD8 T-cells of the blood and spleen than was seen upon i.p. or i.n. infection (Fig. 4f) .
In combination, our data argue that i.n. MCMV infection induces inflationary CD8 T-cell responses and that these inflationary cells retain the EM phenotype, although at slightly lower frequencies than upon i.p. infection.
Latent virus is elevated in the lungs and low in the spleen after i.n. infection
It was suggested recently that the spleen might be an important site for the maintenance of memory inflation (Redeker et al., 2014; Smith et al., 2014) . In this case, the attenuated memory inflation upon i.n. infection (Figs 2-4) may be a reflection of lower splenic viral genome load upon mucosal infection. Hence, we determined the latent load in spleens of 129/Sv mice infected by the different infection routes at 26 weeks p.i. I.p. infection resulted in the highest latent load in the spleen (Fig. 5a ). This pattern was not maintained in lungs, where i.n. infection led to the highest latent viral genomes (Fig. 5b) . The latent genome load was lowest after infection by gavage in both organs (a more detailed comparison of latent loads is provided in Fig. S2) . We repeated this analysis in BALB/c mice with similar results (data not shown).
In summary, our results indicate that the latent MCMV load in an organ depends on the route of infection. Considering the results shown in Fig. 1 , we observed an association between the magnitude of virus replication in an organ during primary infection and the latent genome load during latency.
DISCUSSION
In this study, we systematically compared different routes of MCMV infection. We showed that the i.n. route results in robust and long-lasting virus replication in the lungs and salivary glands, consistent with a previous report (Morello et al., 2005) and is accompanied by memory CD8 T-cell inflation, yet this is impaired upon intragastric infection, even when we optimize pH conditions to avoid virus neutralization prior to its entry into cells. This implies that the respiratory mucosa, rather than the gastrointestinal one, may serve as a major site of virus entry into the host. Previous studies by Stahl et al. (2013) showed similar results in newborn mice, but these authors used transgenic viruses containing three separate mutations, and it remained unclear whether the poor replication in the gut mucosa upon oral infection reflected the biology of the wt MCMV infection. This is in stern contrast with data indicating that intragastric infection of newborn mice with wt MCMV can result in virus dissemination (Wu et al., 2011) . However, that study was based on qualitative PCR of viral nucleic acids, while we measured the replicating virus by a quantitative assay, allowing us not only to identify its presence but also to assess its abundance. Interestingly, the large majority of mice infected by gavage had no detectable viral titres in the tested primary organs (spleen and lungs), but a distinct number of these mice had detectable virus replication in the salivary glands. As the salivary glands are generally thought to be targeted only upon secondary viraemia (Campbell et al., 2008) , this may be explained either by virus replication in a primary organ that was not tested by us or by the possibility that virus might disseminate without a major primary expansion.
Our results suggest that the wt MCMV infection by the intragastric route is substantially less efficient than i.n. infection in adult mice, arguing that the respiratory rather than the gastrointestinal mucosa may be a more dominant natural site of entry of this virus. One needs to note, however, that our study focused only on the respiratory and gastrointestinal epithelium, whereas other mucosal surfaces, such as the genitourinary mucosa or the epithelium of the oral cavity, need to be addressed in future studies. Surprisingly, the high viral titres observed upon i.n. infection resulted in no overt disease. As low pathology is also a feature of primary HCMV infections of adults, one may speculate that i.n. infection reflects a natural infection condition. However, more studies are required to validate this hypothesis.
Most evidence for memory T-cell inflation has rested on systemic experimental infection with a high dose of the virus (Karrer et al., 2003; Munks et al., 2006) . Recently, it was shown that a low-dose inoculum of MCMV results in a severely hampered inflation of memory T-cells (Redeker et al., 2014) , suggesting that the amount of virus is also a determinant of memory inflation. While it is generally accepted that systemic infection occurs during congenital HCMV infection by transfer of the virus through the placenta, infections after birth most likely occur via mucosal routes. Therefore, it was not clear whether infection of adult hosts by a mucosal route would result in a sufficient level of acutely replicating virus to elicit memory inflation. We showed here that inflation of MCMV-specific T-cells can occur upon i.n. infection but is less pronounced than in mice infected by the i.p. route (Fig. 3) .
It has been proposed that intermittent low-level antigen expression during latent MCMV infection induces inflationary CD8 T-cell responses (Seckert et al., 2012) , and it has been reported recently that inflationary responses occur due to the proliferation of T-cells in contact with the blood circulation, rather than in organ parenchyma (Smith et al., 2014) , probably because endothelial cells lining blood vessels are a major site of MCMV latency (Seckert et al., 2009) . If this model is accurate, and considering that mice infected by the i.n. route showed substantially higher latent loads in the lungs but lower ones in the spleen (Fig. 5) , our data imply that latent viral load in the spleen, rather than in the lungs, predicts the magnitude of memory inflation, consistent with the recent observation that CMV-specific T-cells proliferate in the spleen of latently infected mice upon i.p. infection (Redeker et al., 2014) . We focused in our study on prototypical inflationary epitopes. While it is likely that noninflationary epitopes will exhibit a similar hierarchy of responses upon various infection routes, this aspect needs to be formally confirmed in future studies.
Taken together, our results argue that i.p. infection drives inflationary CD8 T-cell responses that are more pronounced than the responses observed upon i.n. infection, but essentially both infection routes induce responses with similar kinetics and phenotypes of responding T-cells. As CMV-induced pneumonia is a major pathology caused by this virus and mucosal infection is likely to reflect the natural infection better than intraperitoneal injection, we propose that the i.n. infection route offers a robust model for the study of CMV replication and latency and mucosal immune responses in a highly relevant site of infection.
METHODS
Mice
BALB/c mice were purchased from Janvier and 129/Sv mice were purchased from Charles River Laboratories. Animals were kept in specific-pathogen-free conditions at the animal facility of the 
Cells
The murine bone marrow stromal cell line M2-10B4 (CRL-1972) (Lemoine et al., 1988a, b) was purchased from the American Type Culture Collection and maintained in DMEM supplemented with 10 % FCS, 1 % glutamine and 1 % penicillin/streptomycin. C57BL/6 murine embryonic fibroblasts (MEFs) were generated and cultured as described previously .
Virus
The BAC-derived mouse cytomegalovirus clone pSM3fr 3.3 (Jordan et al., 2011) was used as MCMV wt ; it was propagated on M2-10B4 cells and titrated on MEFs as described previously .
Infection
Female BALB/c or 129/Sv mice (6-10 weeks old) were infected with 2|10 5 p.f.u. MCMV wt using different infection routes. Virus diluted in 200 ml PBS was i.p. injected. Virus solution (20 ml in PBS) was administered into both nostrils of mice anaesthetized with 10 ml ketamine (10 mg ml 21 ) + xylazine (1 mg ml 21 ) (g body weight) 21 in 0.9 % NaCl. We used ketamine, because isoflurane anaesthesia resulted in less efficient infection (detected by virus titres in the lungs on day 4 p.i.; Fig. S3 ). As a second mucosal route, mice were infected by gavage. Mice were fasted for 5 h and stomach acid was neutralized with 100 ml 5 % NaHCO 3 solution injected into the stomach by a feeder needle prior to infection with virus in 200 ml PBS by the same route.
Determination of infectious virus in organs
Organs were harvested in a sterile manner from infected mice and stored in DMEM at 270 uC until titration. Thawed organs were homogenized on 70 mm pore-size cell strainers in 5 ml DMEM (supplemented with 5 % FBS, 1 % glutamine and 1 % penicillin/ streptomycin) and homogenates were titrated on MEFs with centrifugal enhancement as described previously (Č ičin-Šain et al., 2005) .
Blood and organ collection, processing and counting Blood was collected from the retrobulbar venous plexus of isoflurane anaesthetized mice. Blood (50 ml) was transferred into EDTA reaction tubes and used for lymphocyte counting on a VetScan HM5 Haematocytometer (Abaxis). The remaining blood (approx. 100 ml) was mixed with 300 ml heparin in Hanks' balanced salt solution (2 U ml 21 ) to prevent clotting. Erythrocytes were lysed and cell pellets were stained for flow cytometric analysis.
MLNs and ILNs as well as spleens were harvested in ice-cold RPMI (supplemented with 10 % FBS, 1 % glutamine, 1 % penicillin/streptomycin, 1 % sodium pyruvate and 0.1 % b-mercaptoethanol) before further processing. Organs were homogenized on 70 mm pore-size cell strainers and pelleted by centrifugation. Lymph node samples were resuspended in 300 ml RPMI; 60 ml was used for counting of lymphocytes, and 240 or 80 ml (detailed kinetic) was used for immunofluorescence staining. Erythrocytes were removed from the spleen samples by a 1 min incubation in 5 ml ACK buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 1 mM ETDA; pH 7.3), which was stopped by the addition of 10 ml RPMI, centrifugation, a PBS wash and resuspension in 1 ml RPMI. A volume of 6 ml of each sample was mixed with 54 ml RPMI (1 : 10 dilution) for counting. Additionally, one sample from each group was counted using a Neubauer chamber, and approximately 10 6 cells per sample were used for immunofluorescence staining.
Immunofluorescence staining and flow cytometry analysis Cells were stained for surface markers and multimers recognizing MCMV-specific CD8 T-cells. In this study, MHC-Streptamers recognizing T-cells specific for M38 [316] [317] [318] [319] [320] [321] [322] [323] (   316   SSPPMFRV   323 ) were used in the case of samples from 129/Sv mice and a conventional tetramer binding T-cells specific for IE1/pp89 [168] [169] [170] [171] [172] [173] [174] [175] [176] ) was used for samples from BALB/c mice. All multimers were generated in house as described previously (MHC-Streptamer, Knabel et al., 2002; tetramer, Altman et al., 1996) . MHC multimer staining was initiated for 15 min at 4 uC; subsequently, cell-surface marker antibodies were added and staining was continued for 30 min at 4 uC. IE1-specific tetramer conjugated to allophycocyanin (APC) was directly used with surface marker antibodies to stain cells for 30 min at 4 uC. The following surface marker antibodies were used: anti-CD3-APC-eFluor 780 (clone 17A2; eBioscience), anti-CD4-Pacific blue (clone GK1.5; Biolegend), anti-CD8-PerCp-Cy5.5 (clone 53-6.7; BD Biosciences), anti-CD11a-phycoerythrin-Cy7 (clone 2D7; BD Biosciences), anti-CD44-Alexa Fluor 700 (clone IM7; Biolegend/BD Biosciences), anti-KLRG1-FITC (clone 2F1/KLRG1; Biolegend), anti-CD62L-eFluor605NC (clone MEL-14; eBioscience) and anti-KLRG1-biotin (clone 2F1/KLRG1; Biolegend). For the detection of KLRG1-Biotin a secondary staining with streptavidin-Brilliant Violet 510 (Biolegend) was performed.
After washing cells twice with FACS buffer (2 % FBS in 1| PBS), samples were acquired using an LSR-Fortessa (BD Biosciences). Results were analysed using FlowJo software version 9.7.6 (Treestar).
Quantification of latent viral genomes
For quantification of MCMV genomes, DNA was isolated from spleens or lungs using a DNeasy Blood & Tissue kit (Qiagen) and quantified by M55 (encoding gB)-specific quantitative PCR (qPCR) normalized to cell number by pthrp-specific qPCR as described previously (Lemmermann et al., 2010) .
